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ARTICLE
Truncated SALL1 Impedes Primary Cilia Function
in Townes-Brocks Syndrome
Laura Bozal-Basterra,1 Itziar Martı´n-Ruı´z,1 Lucia Pirone,1 Yinwen Liang,2 Jo´n Otti Sigursson,3
Maria Gonzalez-Santamarta,1 Immacolata Giordano,1 Estibaliz Gabicagogeascoa,1 Angela de Luca,1
Jose A. Rodrı´guez,4 Andrew O.M. Wilkie,5 Ju¨rgen Kohlhase,6 Deborah Eastwood,7 Christopher Yale,8
Jesper V. Olsen,3 Michael Rauchman,9,10,11 Kathryn V. Anderson,2 James D. Sutherland,1,*
and Rosa Barrio1,*
Townes-Brocks syndrome (TBS) is characterized by a spectrum ofmalformations in the digits, ears, and kidneys. These anomalies overlap
those seen in a growing number of ciliopathies, which are genetic syndromes linked to defects in the formation or function of the pri-
mary cilia. TBS is caused by mutations in the gene encoding the transcriptional repressor SALL1 and is associated with the presence of a
truncated protein that localizes to the cytoplasm. Here, we provide evidence that SALL1mutationsmight cause TBS bymeans beyond its
transcriptional capacity. By using proximity proteomics, we show that truncated SALL1 interacts with factors related to cilia function,
including the negative regulators of ciliogenesis CCP110 and CEP97. This most likely contributes to more frequent cilia formation in
TBS-derived ﬁbroblasts, as well as in a CRISPR/Cas9-generated model cell line and in TBS-modeled mouse embryonic ﬁbroblasts, than
in wild-type controls. Furthermore, TBS-like cells show changes in cilia length and disassembly rates in combination with aberrant
SHH signaling transduction. These ﬁndings support the hypothesis that aberrations in primary cilia and SHH signaling are contributing
factors in TBS phenotypes, representing a paradigm shift in understanding TBS etiology. These results open possibilities for the treatment
of TBS.Introduction
Townes-Brocks syndrome (TBS1 [MIM: 107480]) is
characterized by the presence of an imperforate anus
and dysplastic ears and is frequently associated with
sensorineural and/or conductive hearing impairment
and thumb malformations such as triphalangy, duplica-
tions (preaxial polydactyly), and hypoplasia.1 Common
features among TBS individuals include end-stage renal
disease, polycystic kidneys, foot and genitourinary mal-
formations, and congenital heart disease. Although less
common, short ribs, intellectual disability, growth retar-
dation, cleft palate, and eye defects are also observed.
TBS is an autosomal-dominant genetic disease caused by
mutations in SALL1 (SAL-like 1 [MIM: 602218]),2,3 one
of the four members of the SALL gene family in verte-
brates. SALL1 encodes a zinc-ﬁnger transcription factor
linked to chromatin-mediated repression.4 SALL1 is
characterized by the presence of stereotypical pairs of
zinc-ﬁnger domains along the protein, which are thought
to mediate interactions with DNA via an AT-rich
sequence.5 In vertebrates, the N-terminal region of
SALL1 mediates transcriptional repression via its inter-
action with the nucleosome-remodeling deacetylase
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SALL family members.7
Dominant genetic syndromes are often caused by a gain-
of-function or dominant-negative effect of the underlying
mutant proteins. Many TBS-causing SALL1 mutations
could result in truncated proteins that lack most of the
zinc ﬁnger pairs likely to mediate chromatin-DNA interac-
tions but retain the N-terminal domain. In fact, this region
represents a mutational ‘‘hotspot’’ where many nonsense
mutations and deletions causing frameshifts have been
described.3 Mutant SALL1 mRNA transcripts are stable
and resistant to nonsense-mediated decay,8 and the result-
ing truncated proteins are able to interact with the NuRD
complex and perhaps other factors, as well as form dimers
with themselves, with full-length SALL1 (SALL1FL), or with
other SALL proteins.9 Sall1þ/ and Sall1/ mice fail to
show TBS-like phenotypes,10–12 discarding haploinsufﬁ-
ciency as the most plausible cause of the disease. Only
when murine Sall1 is altered to mimic human mutations
(i.e., to generate a truncated protein in a single copy) do
mice display TBS symptoms, such as hearing loss and
anus and limb malformations.11 Because TBS depends on
the presence of a truncated SALL1, elucidating its role
and its possible interference with SALL1FL and other fac-
tors would ﬁll a major gap in our understanding of TBS., Spain; 2Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New
, Faculty of Health and Medical Sciences, University of Copenhagen, Bleg-
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Intriguingly, some TBS features match those seen in cil-
iopathies, diseases linked to the function of primary cilia.13
Ciliopathies present a spectrum of overlapping pheno-
types such as polycystic kidneys, hearing loss, limb defects,
and mental retardation, among others. These coincidental
features could suggest similar cellular and molecular un-
derpinnings between ciliopathies and TBS.
Cilia are microtubule-based organelles that emerge from
centriole-containing basal bodies. Centrioles, together
with their surrounding matrix, the pericentriolar material,
form the centrosome. Once anchored to the plasma mem-
brane, centrioles behave as basal bodies, giving rise to two
different kinds of cilia: motile cilia (or ﬂagella) and primary
cilia. Non-motile primary cilia are present in most verte-
brate cells,14 and ciliary assembly and disassembly are co-
ordinated during the cell cycle.15,16 Primary cilia arise
from the mother centriole (MC) upon entry into the G0
phase, reabsorb as cells progress from the G1 to the
S phase, and completely disassemble in mitosis.17 Cilia
assembly is tightly controlled by essential proteins that
contribute to structure and transport to, from, or within
the cilia and counterbalanced with negative regulators. Pri-
mary cilia have a crucial role in cell signaling, polarity, and
protein trafﬁcking. During development, the vertebrate
Sonic Hedgehog (SHH) pathway is crucial for vertebrate
digit patterning and is fully dependent on primary
cilia.18,19 In brief, SHH activation through its receptor
PTCH1 leads to ciliary enrichment of the transmembrane
protein Smoothened (SMO) and a concomitant conversion
of the transcription factor GLI3 from a repressor to an
activator, leading to activation of SHH target genes, such
as GLI1 (GLI family zinc ﬁnger 1 [MIM: 165220])
and PTCH1 (patched 1 [MIM: 601309]). The trafﬁcking
through primary cilia is tightly regulated by several
anterograde and retrograde systems.20,21 Mutations in
genes that encode intraﬂagellar transport proteins deregu-
late SHH signaling and result in limb and neural-
tube-closure defects, phenotypes similar to those result-
ing from mutations of genes encoding SHH pathway
components.22–24
Here, we show that TBS-derived primary ﬁbroblasts
exhibit changes in SALL1FL localization, a higher rate of cil-
iogenesis, abnormally elongated cilia, aberrant cilia disas-
sembly, and SHH signaling defects. Through proximity
proteomics, we identiﬁed two main ciliogenesis suppres-
sors, CCP110 (centriolar coiled-coil protein of 110 kDa)
and CEP97 (centrosomal protein of 97 kDa), as interactors
of TBS-causing truncated SALL1. The higher rate of cilio-
genesis detected in TBS-derived ﬁbroblasts is consistent
with an observed lower amount of CCP110 and CEP97 at
the MC in these ﬁbroblasts than in controls.
Furthermore, truncated SALL1, alone or in complex with
SALL1FL, interacts with CCP110 and CEP97 in the cyto-
plasm of individual-derived ﬁbroblasts, which most likely
leads to a reduction of CCP110 and CEP97 at the MC by
sequestration. These results indicate that truncated pro-
teins arising from certain SALL1mutations can disrupt cilia250 The American Journal of Human Genetics 102, 249–265, Februarformation and function. Therefore, TBS might be consid-
ered a ciliopathy-like disease.Material and Methods
Cell Culture
TBS-derived primary ﬁbroblasts, mouse embryonic ﬁbroblasts
(MEFs), HEK293FT cells (Invitrogen), U2OS cells (ATCC HTB-96),
and mouse Shh-LIGHT2 cells25 were cultured at 37C and 5%
CO2 in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS; GIBCO) and 1% peni-
cillin and streptomycin (GIBCO). Human TERT-RPE1 cells (ATCC
CRL-4000) were cultured in DMEM/F12 (GIBCO) supplemented
with 10% FBS and 1% penicillin and streptomycin. Dermal ﬁbro-
blasts carrying a SALL1 c.995delC mutation, which produces a
truncated p.Pro332Hisfs*10 protein, were derived from male TBS
individual OX3335 (TBSp.Pro332Hisfs*10 herein).3,8 Dermal ﬁbro-
blasts carrying the SALL1 pathogenic variant c.826C>T, which
produces a truncated p.Arg276* protein, were derived from male
TBS individual UKTBS#3 (TBSp.Arg276* herein). Human neonatal
foreskin ﬁbroblasts (HFFs; ATCC CRL-2429) and adult female
dermal ﬁbroblasts (ESCTRL#2) from healthy donors were used as
controls. We derived MEFs from wild-type (WT) and three hetero-
zygous embryos carrying the Sall1-DZn2–10mutant allele.11 All the
embryos were at embryonic day 13. WT and mutant alleles were
detected by PCR genotyping using established methods. Cultured
cells were maintained between 10 and 20 passages, tested for
senescence by g-H2AX staining, and grown until conﬂuence
(6-well plates for RNA extraction and western blot assays; 10 cm
dishes for pull-downs). Most cells were transfected with calcium
phosphate, but primary ﬁbroblasts were transfected with Lipofect-
amine 3000 (Invitrogen). To induce primary cilia, we starved cells
for 24 or 48 hr (DMEM, 0.1% FBS, 1% penicillin, and strepto-
mycin). In the case of HEK293FT cells, we followed the conditions
recently reported.26 The use of human samples in this study was
approved by the ethics committee at CIC bioGUNE, and appro-
priate informed consent was obtained from human subjects.
Work with mouse embryos to derive MEFs was approved by Saint
Louis University. All experiments conformed to the relevant regu-
latory standards.Plasmid Construction
A full-length (FL) human SALL1 clone was used for high-ﬁdelity
PCR ampliﬁcation and subcloning into EYFP-N1 (Clontech) as
truncated (SALL1c.826C>T-YFP) or FL (SALL1FL-YFP) versions.
Clones, corresponding to current annotations, were validated by
Sanger sequencing (GenBank: NM_002968.2). We exchanged
EYFP for two copies of the HA tag to build SALL1FL-2xHA. For
BioID vectors, Ac5-STABLE2-neo27 was modiﬁed to contain a
CAG promoter, a Myc-tagged version of BirA (R118G, human
codon optimized), and a multiple cloning site into which
SALL1c.826C>Tor SALL1FLwas inserted.28 Lentiviral expression vec-
tors were prepared in Lentilox-GFS-IRESpuro, a derivative of LL3.7
(GFS ¼ GFP-FLAG-STREP).29SALL1 Proximity Proteomics
With the BioID method,28 proteins in close proximity to
SALL1 were biotinylated by fusion to a promiscuous form of the
enzyme BirA (BirA*) and isolated by streptavidin-bead pull-downs.
Myc-BirA*-SALL1c.826C>T or Myc-BirA*-SALL1FL was transfected iny 1, 2018
HEK293FTcells (ﬁve 10 cm dishes per condition). 24 hr after trans-
fection, medium was supplemented with biotin at 50 mM. Cells
were collected after 48 hr, washed three times on ice with cold
phosphate-buffered saline (PBS), and scraped in lysis buffer (8 M
urea, 1% SDS, 13 protease inhibitor cocktail [Roche], and 13
PBS; 1 mL per 10 cm dish). At room temperature, samples were
sonicated and cleared by centrifugation. Cell lysates were incu-
bated overnight with 40 mL of equilibrated NeutrAvidin-agarose
beads (Thermo Scientiﬁc). Beads were subjected to stringent
washes using the following washing buffers (WBs), all prepared
in PBS: WB1 (8 M urea and 0.25% SDS), WB2 (6 M guanidine-
HCl), WB3 (6.4 M urea, 1 M NaCl, and 0.2% SDS), WB4 (4 M
urea, 1 M NaCl, 10% isopropanol, 10% ethanol, and 0.2% SDS),
WB5 (8 M urea and 1% SDS), and WB6 (2% SDS). For elution of
biotinylated proteins, beads were heated at 99C in 50 mL of
elution buffer (43 Laemmli buffer and 100 mM DTT). Beads
were separated by centrifugation (18,0003 g for 5 min) or alterna-
tively removed by centrifugation through a 0.8 mmﬁlter (Vivaspin,
Sartorius). Samples were used for mass spectrometry (MS) analysis
as well as for western blotting for validation of selected candidates.Mass Spectrometry
Three independent pull-down experiments were analyzed by MS.
Samples eluted from the NeutrAvidin beads were separated in
SDS-PAGE and stained with Brilliant Blue G-Colloidal Concen-
trate (Sigma) according to the manufacturer’s instructions. The
entire gel lanes were excised, divided into pieces, and destained,
and proteins were reduced and alkylated before being in situ di-
gested with trypsin. The resulting peptide mixtures were ex-
tracted, concentrated, and analyzed with an EASY nLC system
(Proxeon). Peptides were ionized with a Proxeon ion source and
sprayed directly into the mass spectrometer (Q-Exactive, Thermo
Scientiﬁc). MaxQuant software (version 1.4.0.3) was used for the
processing and analysis of recorded liquid chromatography tan-
dem MS (LC-MS/MS) raw ﬁles with default parameters and
applying a 1% false-discovery rate at both the peptide and pro-
tein levels. Label-free quantitation based on summed extracted
peptide ion chromatograms was used for identifying differentially
interacting proteins.
The lists of proteins identiﬁed by LC-MS/MS were analyzed as
follows: only proteins identiﬁed by more than one peptide and
present in at least two out of the three experiments were consid-
ered for analysis. Protein IDs were ranked according to the number
of peptides found and their corresponding intensities. Hits were
classiﬁed into those that interact with both FL and truncated
SALL1p.Arg276* and those interacting preferentially with one or
the other. A threshold of 2-fold change in iBAQ (intensity-based
absolute quantiﬁcation) value was considered signiﬁcant. For
each experiment, calculation took into account a baseline that
corresponded to the minimum value of iBAQ registered for every
speciﬁc sample.
Enrichment of Gene Ontology (GO) terms was analyzed with
g:Cocoa, a tool integrated in the g:Proﬁler web server.30 GO enrich-
ment was obtained by calculation of the log10 of the p value.Western Blot Analysis
Cells were lysed in cold RIPA buffer supplemented with 13 prote-
ase inhibitor cocktail (Roche). Lysates were kept on ice for 30 min
with vortexing every 5 min and then cleared by centrifugation
(25,000 3 g for 20 min at 4C). Supernatants were collected,
and protein contents were quantiﬁed by a BCA protein quantiﬁ-The Americacation assay (Pierce). After SDS-PAGE and transfer to nitrocellu-
lose or polyvinylidene ﬂuoride, membranes were blocked in 5%
milk in 13 PBS and 0.1% Tween-20. For anti-biotin, blocking
was performed in casein. In general, primary antibodies were
applied overnight at 4C, and secondary antibodies were applied
for 1 hr at room temperature. Antibodies used included CCP110
(Proteintech; 1:1,000), CEP97 (Proteintech; 1:1,000), Biotin
(Biotin-HRP Cell Signaling; 1:2,000), HA (Sigma; 1:1,000), GFP
(Roche; 1:1,000), tubulin-HRP (Proteintech; 1:2,000), GAPDH-
HRP (Proteintech; 1:1,000), and Actin (Sigma; 1:1,000). The
anti-SALL1 antibodies used detect speciﬁcally SALL1FL (R&D; aa
258–499) or the N-terminal part of SALL1.6 Secondary antibodies
were HRP-conjugated anti-mouse or anti-rabbit (Jackson Immu-
noresearch). Proteins were detected with Clarity ECL (BioRad)
or Super Signal West Femto (Pierce). Quantiﬁcation of bands
was performed with ImageJ software and normalized against
actin or GAPDH levels. At least three independent blots were
quantiﬁed per experiment.GFP Pull-Downs
All steps were performed at 4C. HEK293FT-transfected cells were
collected after 48 hr, washed three times with 13 PBS, and lysed
in 1 mL of lysis buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl,
1 mM EDTA, 1% NP-40, 0.5% Triton X-100, 5% glycerol, and pro-
tease inhibitors [Roche]). Lysates were kept on ice for 30 min with
vortexing every 5 min and spun down at 25,000 3 g for 20 min.
After 40 mL of supernatant (input) was saved, the rest was incu-
bated overnight with 30 mL of pre-washed GFP-Trap resin (Chro-
motek) in a rotating wheel. Beads were washed ﬁve times for
5 min each with WB (25 mM Tris-HCl [pH 7.5], 300 mM NaCl,
1 mM EDTA, 1% NP-40, 0.5% Triton X-100, and 5% glycerol).
Beads were centrifuged at 2,000 3 g for 2 min after each wash.
For elution, samples were boiled for 5 min at 95C in 23 Laemmli
buffer.Immunoprecipitation
All steps were performed at 4C. HEK293FT-transfected cells
were collected after 48 hr, washed 3 times with 13 PBS, and
lysed in 1 mL of lysis buffer (20 mM Tris-HCl [pH 7.5],
137 mM NaCl, 2 mM EDTA, 1% NP-40, 5% glycerol, and prote-
ase inhibitor mixture [Roche]). Lysates were processed as
described for GFP pull-downs. The rest was incubated overnight
with 1 mg of CCP110 or CEP97 antibody (Proteintech) and for an
additional 4 hr with 40 mL of pre-washed Protein G Sepharose 4
Fast Flow beads (GE Healthcare) in a rotating wheel. Beads
were washed ﬁve times for 5 min each with WB (10 mM
Tris-HCl [pH 7.5], 137 mM NaCl, 1 mM EDTA, and 1% Triton
X-100). Beads were centrifuged at 2,000 3 g for 2 min after
each wash. For elution, samples were boiled for 5 min at 95C
in 23 Laemmli buffer.Immunostaining
hTERT-RPE cells, U2OS cells, and primary ﬁbroblasts from con-
trol and TBS individuals were seeded on 11 mm coverslips
(25,000 cells per well on a 24-well plate). We plated HEK293FT
cells on coverslips coated with 0.01% poly-L-lysine (Sigma)
to enhance adhesion. After being washed three times with
cold 13 PBS, cells were ﬁxed with 4% paraformaldehyde
(PFA), 0.1% Triton X-100 in 13 PBS for 20 min on ice,
and then washed three times with 13 PBS or pre-permeabilized
for 2 min in PTEM buffer (20 mM PIPES [pH 6.8], 0.2% Tritonn Journal of Human Genetics 102, 249–265, February 1, 2018 251
X-100, 10 mM EGTA, and 1 mM MgCL2)
31 and ﬁxed for 10 min
with 4% PFA for centrosomal staining. Blocking was performed
for 1 hr at 37C in blocking buffer (BB: 2% fetal calf serum and
1% BSA in 13 PBS). Primary antibodies were incubated over-
night at 4C, and cells were washed with 13 PBS three times.
To label the ciliary axoneme as well as the basal body and peri-
centriolar regions, we used mouse antibodies against acetylated
alpha-tubulin (Sigma) and gamma-tubulin (Sigma) or rabbit an-
tibodies against ARL13B (Proteintech) and pericentrin (Covance;
1:160). Other antibodies included were mouse anti-SALL1 (R&D;
1:100), rabbit anti-CCP110 (Proteintech; 1:100), rabbit anti-
CEP97 (Proteintech; 1:100), mouse monoclonal anti-CEP164
(Genetex; 1:100), rabbit anti-ODF2 (Atlas; 1:100), and mouse
anti-phospho-Histone H2A.X (Millipore; 1:500).
Donkey anti-mouse or anti-rabbit secondary antibodies (Jack-
son Immunoresearch) conjugated to Alexa 488 or 568 (1:200)
were incubated for 1 hr at 37C and then nuclear stained with
DAPI (Sigma; 10 min; 300 ng/mL in PBS). Transfected HEK293FT
cells with Myc-BirA*-SALL1c.826C>T or Myc-BirA*-SALL1FL were
incubated with 50 mM biotin for 24 hr, washed, ﬁxed, and
stained with Alexa-594-conjugated Streptavidin (Jackson Immu-
noresearch; 1:100). Fluorescence imaging was performed with
an upright ﬂuorescent microscope (Axioimager D1, Zeiss) or
confocal microscope (Leica SP2) with a 403, 633, or 1003
objective. For cilia measurements and counting, primary cilia
from at least 15 different ﬂuorescent micrographs from each
experimental condition were analyzed with the ruler tool from
Adobe Photoshop. We calculated cilia frequency by dividing
the number of total cilia by the number of cells on each micro-
graph. The number of cells per micrograph was similar in both
TBS and control ﬁbroblasts. To obtain the level of ﬂuorescence
in a determined region, we calculated the corrected total cell
ﬂuorescence as previously described32 by using parameters ob-
tained by ImageJ.qPCR Analysis
TBSp.Pro332Hisfs*10 and control ﬁbroblasts were starved for 24 hr,
and then they were either treated or not with purmorphamine
for 24 or 48 hr (while starvation conditions were maintained) to
induce the SHH signaling pathway. Total RNA was obtained with
the EZNA Total RNA Kit (Omega) and quantiﬁed with a Nanodrop
spectrophotometer. cDNAs were prepared with the SuperScript III
First-Strand Synthesis System (Invitrogen) in a 20 mL volume per
reaction. GLI1, PTCH1, and control GAPDH primers were tested
for efﬁciency, and products were checked for the correct size before
being used in test samples. qPCR was done with Mi-Hot Taq Mix
(Metabion). Reactions were performed in 10 mL by the addition
of 1 mL of cDNA, 203 Evagreen (Biotium), and 0.5 mL of each
primer (10 mM) to a CFX96 thermocycler (Bio-Rad) according to
the following protocol: 95C for 10 min and 40 cycles of 95C
for 10 s and 60C for 30 s. Melting curve analysis was performed
for each pair of primers between 65C and 95C with 0.5C tem-
perature increments every 5 s. Relative gene expression data
were analyzed by the DDCt method. Reactions were done in trip-
licates, and results were derived from at least three independent
experiments normalized to GAPDH and presented as relative
expression levels. Individual expression values were normalized
to GAPDH. Primer sequences were as follows: GLI1-F, 50-AGCCTT
CAGCAATGCCAGTGAC-30; GLI1-R, 50-GTCAGGACCATGCACT
GTCTTG-30; PTCH1-F, 50-CTCATATTTGCCTTCG-30; PTCH1-R,
50-TCTCCAATCTTCTGGCGAGT-30; GAPDH-F, 50-AGCCACAT252 The American Journal of Human Genetics 102, 249–265, FebruarCGCTCAGACAC-30; and GAPDH-R, 50-GCCCAATACGACCAA
ATCC-30.
CRISPR/Cas9 Genome Editing
We performed CRISPR/Cas9 targeting of the SALL1 locus to
generate a HEK293FT cell line carrying a TBS-like allele. We
used online resources (CRISPRdesign and CRISPOR) to search
for high-scoring sites in proximity to the site mutated in the
TBSp.Pro332Hisfs*10 ﬁbroblasts. We chose the highest-scoring
sgRNA target to design our vectors. All constructs were
conﬁrmed by sequencing, and cloning details are available
upon request. Transient transfection and puromycin selection
were followed by single-cell cloning and screening. After
CRISPR/Cas9-mediated cutting, the resulting repair gave rise to
the single-base insertion c.1003dup in SALL1; this change is pre-
dicted to give rise to the following protein: SALL1p.Ser335Lysfs*20.
This mutation was conﬁrmed to be heterozygous by Sanger
sequencing of a pooled mutant and WT amplicon, as well as in-
dividual sequencing of TOPO-cloned amplicons (both mutant
and WT were detected).
Using the same online resources, we chose six of the highest-
scoring off-target sites for additional analysis (mm2_
exon_SALL1P1_chrX_49432372, mm4_exon_NACA_chr12_
57110706; mm4_intergenic_CDCA7LjRAPGEF5_chr7_22092853;
mm4_intergenic_RNU6-996PjAL162389.1_chr9_110472444;mm4_
exon_LEMD2_chr6_33744586; and mm4_exon_GPRIN2_chr10_
46999700). Using genomic DNA from our targeted clone as a
template, we performed PCR and Sanger sequencing. In all
cases, no mutations were found.
SALL1 Silencing
A human SALL1 target sequence (50-CTGCTATTTGTATTGTGC
TTT-30, based on validated Mission shRNA TRCN0000003958;
Merck, Sigma-Aldrich) was cloned into the inducible shRNAvector
Tet-pLKO-puro (Addgene 21915).33 Lentivirus was produced in
HEK293FT cells and used for transducing and stably selecting
HEK293FT cells with puromycin (1 mg/mL). SALL1 silencing was
induced for 72 hr with doxycycline (1 mg/mL).
Lentiviral Transduction
Lentiviral expression constructs were packaged with psPAX2 and
pVSVG (Addgene) in HEK293FT cells, and lentiviral supernatants
were used for transducing Shh-LIGHT2 and hTERT-RPE1 cells.
Stable-expressing populations were selected with puromycin
(1 mg/mL). For primary ﬁbroblasts, lentiviral supernatants were
concentrated100-foldbeforeuse (Lenti-X concentrator, Clontech).
Luciferase Assays
Fireﬂy luciferase expression was measured with the Dual-Lucif-
erase reporter system (Promega) according to the manufacturer’s
instructions. For each construct, we divided luciferase activity
upon purmorphamine treatment by the activity of cells before
purmorphamine induction to obtain the fold-change value. Lumi-
nescence was measured, and data were normalized to the Renilla
luciferase readout. Experiments were performed with both biolog-
ical and technical replicates (n ¼ 8).
Statistical Analysis
Statistical analyses were performed with GraphPad 6.0 software.
Data were analyzed by the Shapiro-Wilk normality test and
Levene’s test of variance. We used two-tailed unpaired Student’sy 1, 2018
t tests or Mann-Whitney U tests for comparing two groups and
one-way ANOVA or the Kruskall-Wallis test for more than two
groups. Signiﬁcance was considered when p < 0.05.Results
TBS-Derived Cells Show Increased Cilia Frequency and
Length
On the basis of the phenotypic characteristics found
in TBS individuals, we hypothesized that the formation
of primary cilia might be altered in TBS cells. Therefore,
we checked cilia assembly and disassembly in
ﬁbroblasts derived from both control (HFFs) and TBS
(TBSp.Pro332Hisfs*10) individuals (see Material and
Methods).3,8 We induced the assembly of primary cilia by
starving cells at high conﬂuence for 48 hr, whereas we
induced cilia disassembly by adding complete media to
ciliated cells that had previously been subjected to serum
starvation. We quantiﬁed the frequency of ciliation and
the length of primary cilia at all mentioned time points.
TBS ﬁbroblasts formed primary cilia at a signiﬁcantly
higher frequency when the cells were not subjected to star-
vation (Figures 1A–1C). 7.9% of the control cells (versus
24.7% of the TBS cells) exhibited a primary cilium in
cycling conditions (Figure 1C). TBS cells were also signiﬁ-
cantly more ciliated than control ﬁbroblasts upon 48 hr
of starvation. In those conditions, 36.1% of the control
cells (versus 78.8% of the TBS ﬁbroblasts) displayed a pri-
mary cilium. In addition, TBS cells were signiﬁcantly
more ciliated 30 min and 2 hr after serum induction
(Figure 1C). Whereas 100% of the control cells had
completely dismantled their cilia 24 hr after cilia disas-
sembly was induced, 12% of the TBS ﬁbroblasts were still
ciliated (data not shown). Furthermore, primary cilia
were signiﬁcantly longer in TBS cells upon 48 hr of starva-
tion than in control cells (average 3.2 mm in control versus
3.7 mm in TBS cells) (Figure 1D). Cilia were signiﬁcantly
longer in TBS than in control cells at all the studied time
points during cilia disassembly (30 min with complete me-
dium: average 2.6 mm in control versus 3.7 mm in TBS cells;
2 hr with complete medium: 1.9 mm in control versus 3 mm
in TBS cells). The observed increase in cilia frequency after
the addition of complete medium in control cells is consis-
tent with a reported reciliation wave during the ﬁrst hours
of cilia disassembly.34 These results show that TBS cells
have longer and more abundant primary cilia than control
cells in all tested conditions.
As mentioned previously, it has been reported that the
presence of truncated SALL1 is sufﬁcient to cause a TBS-
like phenotype in a mouse model.12 To generate a mutated
form for exogenous expression, we chose the mutation
SALL1c.826C>T because it has been reported in several indi-
viduals with TBS3 and is thus the most common allele in
this rare syndrome. Conﬂuent hTERT-RPE1 cells stably
transduced with lentiviral GFS-SALL1c.826C>T displayed
longer cilia (11 mm on average) than those stable for GFSThe Americaalone (8 mm on average) (Figures 1E and 1F), further con-
ﬁrming that the presence of a truncated form of SALL1 is
sufﬁcient to promote longer cilia. Together, these results
suggest that truncated SALL1 can affect cilia frequency,
as well as the dynamics of cilia assembly and disassembly.
Truncated SALL1 Recruits SALL1FL to the Cytoplasm in
TBS-Derived Fibroblasts
In humans, a truncated SALL1 was observed in B cells
derived from a TBS individual,12 but its presence in ﬁbro-
blasts has not been reported. It was previously shown
that mRNA from the truncated allele was expressed in
TBSc.995delC ﬁbroblasts,8 so we checked for the presence
of truncated SALL1 by western blot. For that, we took
advantage of distinct antibodies recognizing different epi-
topes of SALL1 (see Material and Methods; Figures S1A,
S1B, and S2), which allowed us to distinguish SALL1FL
from the truncated forms. Using an antibody directed
against the N-terminal portion of SALL1, we identiﬁed a
truncated protein of about 62 kDa in TBSp.Pro332Hisfs*10 cells
but not in control ﬁbroblasts (Figure S1C). Furthermore,
SALL1FL was less abundant in TBS cells than in control
HFFs. As previously reported, the observed size of SALL1
by western blot was higher than expected.12
SALL1FL proteins are normally enriched in the nucleus,
whereas truncated forms have been observed in both the
nucleus and cytoplasm.7,35 These studies used overexpres-
sion of truncated murine or chicken forms of Sall1, which
induced a mislocalization of SALL1FL into the cytoplasm,
most likely as a result of the interaction of the different
SALL1 proteins through their glutamine-rich do-
mains.7,35 We therefore analyzed whether the reported
change in localization of endogenous SALL1 was also
occurring in human TBSp.Pro332Hisfs*10 cells. By immuno-
ﬂuorescence, TBSp.Pro332Hisfs*10 ﬁbroblasts presented
abnormal cytoplasmic staining of SALL1FL (Figures S3A
and S3B). We quantiﬁed the ﬂuorescence intensity of
SALL1FL in the nuclei and cytoplasm in both control
HFFs and TBSp.Pro332Hisfs*10 human ﬁbroblasts. SALL1FL in-
tensity was signiﬁcantly lower in the nuclei but signiﬁ-
cantly higher in the cytoplasm of TBS ﬁbroblasts, leading
to a decrease in the nuclear/cytoplasmic ratio
(Figure S3C). No signiﬁcant differences in nuclear or cyto-
plasmic size were found between control and TBS ﬁbro-
blasts, indicating that the changes in intensity were not
due to differences in size (Figure S3D).
To check whether the presence of the truncated protein
in human cells is sufﬁcient to produce the localization
change of SALL1FL, we transiently transfected U2OS cells
with SALL1FL-2xHA, with SALL1c.826C>T-YFP, or with a
combination of both. As expected, SALL1p.Arg276*-YFP
localization was diffuse in the nucleus and cytoplasm
(Figure S1D), whereas SALL1FL localization was limited to
the nuclei in a typical pattern of subnuclear spots
(Figure S1E). However, in the presence of SALL1p.Arg276*,
SALL1FL changed its localization and colocalized with
SALL1p.Arg276* (Figure S1F).n Journal of Human Genetics 102, 249–265, February 1, 2018 253
Figure 1. TBSp.Pro332Hisfs*10 Cells Show Aberrant Cilia Frequency and Length
(A and B) Micrographs of control HFFs (A) or TBSp.Pro332Hisfs*10 cells (TBS332) (B) analyzed during cilia assembly and disassembly.
Cilia were visualized by ARL13B (purple), basal bodies were visualized by pericentrin (green), and nuclei were visualized by DAPI
(blue).
(C and D) Graphical representation of cilia frequency (C) and cilia length (D) measured in control HFFs (blue circles; n ¼ 58 cilia) or
TBS332 cells (orange triangles; n ¼ 116 cilia) from three independent experiments. Cells that underwent 48 hr of starvation were
compared with non-starved cells. After starvation, cells were supplied with serum for 30 min or 2 hr (n ¼ 21–30 micrographs for all
cases).
(E) Micrographs of RPE1 cells infected with lentivirus expressing GFS alone (left) or GFS-SALL1c.826C>T (GFS-SALL1276; right) and labeled
with ARL13B (purple) and DAPI (blue).
(F) Graphical representation of cilia lengthmeasured in control (blue circles; n¼ 43 cilia) or GFS-SALL1276 (orange triangles; n¼ 36 cilia)
RPE1 cells infected as in (E).
Graphs represent mean and SEM of three independent experiments. p values were calculated with a two-tailed unpaired Student’s
t test: *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars, 5 mm.New TBS-Derived Cell Line Exhibits Cilia Alterations
To further verify these results, we analyzed the amount
of SALL1 and cilia formation in ﬁbroblasts derived
from an additional individual referred to as TBSp.Arg276*254 The American Journal of Human Genetics 102, 249–265, Februar(Figure 2A). Of note, this is the same truncation that
was used in our exogenous expression constructs
(i.e., SALL1c.826C>T). When analyzing TBSp.Arg276* cells,
we observed less SALL1FL than in control ESCTRL#2y 1, 2018
Figure 2. Fibroblasts Derived from an
Additional TBS Individual Exhibit Cilia
Anomalies
(A) Clinical ﬁndings in individual
TBSp.Arg276* (TBS276).
(B) Western blot analysis of lysates from
control ESCTRL#2 and TBS276. Samples
were run in duplicate on the same gel
and probed against SALL1FL (asterisk,
R&D antibody) or against SALL1276 (black
arrowhead, N-terminal speciﬁc antibody6)
TBS276 cells encoded with a 48 kDa trun-
cated protein that positively reacts against
SALL1 antibody. Vinculin and GAPDH
were used as loading controls. Molecular-
weight markers are shown to the right.
(C and D) Confocal micrographs showing
endogenous SALL1FL localization in con-
trol ESCTRL#2 (C) or TBS276 (D) ﬁbroblasts
detected by FL-speciﬁc antibody (R&D).
DAPI was used to label the nuclei (blue),
and black and white images show the sin-
gle green channel. Scale bars, 5 mm.
(E and F) Immunoﬂuorescence micro-
graphs showing cilia marked with acety-
lated tubulin (purple), basal bodies marked
with ODF2 (green), and nuclei marked
with DAPI (blue) in control ESCTRL#2
and TBS276 ﬁbroblasts. Pictures were taken
with a Zeiss Axioimager D1 ﬂuorescence
microscope with a 633 objective. Scale
bars, 2.5 mm.
(G and H) Graphical representation of cilia
length measurements (G; n ¼ 123 and 235
cilia for control ESCTRL#2 and TBS276 ﬁ-
broblasts, respectively) and cilia frequency
(H; n ¼ 28 and 31 micrographs for control
ESCTRL#2 and TBS276 ﬁbroblasts, respec-
tively) of micrographs as shown in (E)
and (F). Three independent experiments
were pooled together. The graphs repre-
sent the mean and SEM. The p values
were calculated with a two-tailed unpaired
Student’s t test: ***p < 0.001.
(I and J) Confocal micrographs showing
SALL1FL-YFP localization in control
ESCTRL#2 and TBS276 ﬁbroblasts. Actin is
labeled by phalloidin (purple), and nuclei
are labeled by DAPI (blue). Black and white
images show the single green channel.
Scale bars, 5 mm.cells and the presence of a new band of about 42 kDa,
consistent with a truncated SALL1 (Figure 2B and
Figure S2). Interestingly, localization of SALL1FL was also
altered in human TBSp.Arg276* cells (Figures 2C and 2D).
Furthermore, compared with control ESCRTL#2 cells,
TBSp.Arg276* cells displayed longer and more abundant
cilia in conﬂuent starved conditions, similar to what
was observed in TBSp.Pro332Hisfs*10 cells (Figures 2E–2H).
To check whether the presence of the truncated proteinThe American Journal of Human Genin primary human cells is sufﬁcient
to produce the localization change
of SALL1FL, we transiently trans-
fected control and TBSp.Pro332Hisfs*10cells with SALL1FL-YFP. SALL1FL localization was limited
to the nuclei in control ﬁbroblasts (Figure 2I), whereas
its localization was diffuse in the nucleus and cytoplasm
in TBSp.Arg276* cells (Figure 2J). Thus, truncated SALL1 is
present in TBS-derived cells and leads to altered SALL1FL
localization, most likely through recruitment to the
cytoplasm. As a result, the truncated SALL1, SALL1FL, or
both can potentially interact and interfere with other
proteins.etics 102, 249–265, February 1, 2018 255
Figure 3. TBSp.Pro332Hisfs*10 Fibroblasts
Show Aberrant SHH Signaling
(A and B) Graphical representation of the
fold change of activation based on the rela-
tive expression of GLI1 (A) and PTCH1 (B)
obtained by qPCR from control HFFs
(n¼ 4; blue bars) or TBSp.Pro332Hisfs*10 ﬁbro-
blasts (TBS332) (n ¼ 4; orange bars) either
treated or not () with purmorphamine
for the indicated times. Numerical values
for the fold change are indicated.
(C) Western blot analysis of lysates
from control ESCTRL#2 and TBSp.Arg276*
(TBS276). Samples were probed against
GLI3 (A, activator;R, repressor), andGAPDH
was used as a loading control. Molecular-
weight markers are shown to the right.
(D) Graphical representation is shown
for the fold change of the GLI3-A:GLI3-R
ratios obtained in (C) for control and
TBS ﬁbroblasts. Data from at least three in-
dependent experiments using ESCTRL#2
(control; n ¼ 3; blue bars) and TBS
(TBS276* and TBS332; pooled; n ¼ 5; orange
bars) are shown.
(E) Graphical representation of the fold
change in luciferase activation when
Shh-LIGHT2 control cells (n ¼ 8; blue
bars) or cells expressing the mutated form
GFS-SALL1c.826C>T (SALL1276; n ¼ 8; or-
ange bars) were either treated (þ) or not
() with purmorphamine.
All graphs represent the mean and SEM.
p values were calculated with a two-tailed
unpaired Student’s t test: *p < 0.05, **p <
0.01, ***p < 0.001.TBS-Derived Cells Exhibit Aberrant Sonic Hedgehog
Signaling
It is well established that SHH signal transduction is depen-
dent on the presence of functional primary cilia in mam-
mals.18,19 Therefore, we examined whether SHH signaling
is compromised in TBSp.Pro332Hisfs*10 cells. We starved cells
for 24 hr and incubated in the presence or absence of pur-
morphamine (a SMO agonist) for 24 or 48 hr to activate the
SHH pathway. mRNA expression of two SHH target genes
(GLI1 and PTCH1) was quantiﬁed by qRT-PCR (Figures
3A and 3B). We found that, after induction by purmorph-
amine for 24 or 48 hr, the relative increases in expression
(fold change) of GLI1 and PTCH1 were higher in TBS cells
than in control HFFs. To further study the role of SALL1
truncations in SHH signaling, we analyzed GLI3 processing
by western blot analysis using total lysates extracted from
control and TBS ﬁbroblasts (Figure 3C). We found that
the increase in the GLI3-A/GLI3-R ratio (activator/repre-
sor) upon purmorphamine treatment was signiﬁcantly
higher in TBS cells than in control ﬁbroblasts (Figures 3C
and 3D). We also examined the effects of truncated
SALL1 on SHH signaling by using Shh-LIGHT2 cells.25
These are NIH 3T3mouse ﬁbroblasts that carry an incorpo-
rated SHH reporter (ﬁreﬂy luciferase under the control of
the Gli3-responsive promoter). We observed aberrations
in SHH signaling between Shh-LIGHT2 cells stably express-256 The American Journal of Human Genetics 102, 249–265, Februaring GFS-SALL1c.826C>T and controls (Figure 3E). Like TBS-
derived cells, Shh-LIGHT2 cells overexpressing GFS-
SALL1c.826C>T were more sensitive to SHH induction than
control cells (2.3-fold induction in control cells versus
3.8-fold induction in cells expressing GFS-SALL1c.826C>T).
Defects in PTCH1 and GLI1 expression (endogenous or
via reporter assay) and impaired GLI3 processing conﬁrm
that truncated SALL1 proteins found in TBS might cause
not only defects in ciliogenesis but also defects in SHH
signaling.
Proximity Proteomics of SALL1 Identifies Interactions
with Cilia Regulators
Given that truncated SALL1 proteins and SALL1FL display
differential subcellular localization, we reasoned that TBS
might be a consequence of aberrant cytoplasmic interac-
tions by the truncated SALL1. In order to identify those
possible interactors, we applied proximity proteomics to
either SALL1p.Arg276* or SALL1FL. The BioID method28 re-
lies on a mutant BirA enzyme (BirA*) that has a relaxed
speciﬁcity and is able to biotinylate any free lysine ε-amino
group present in a protein within a radius between 10 and
20 nm.36,37When fused to SALL1p.Arg276* or SALL1FL, BirA*
can biotinylate proximal proteins that either interact
directly with them or are closely associated in protein
complexes.y 1, 2018
Figure 4. CCP110 and CEP97 Interact
with Truncated SALL1
(A and B) Confocal micrographs showing
transient expression of transfected BirA*-
SALL1FL (A) or BirA*-SALL1c.826C>T (BirA*-
SALL1276) (B) detected by ﬂuorescence
streptavidin. Nuclei are marked by DAPI
in blue. Single green channels are shown
in black and white (A0 and B0). Scale bars,
5 mm.
(C) Venn diagram showing the distribu-
tion of the identiﬁed candidates by MS
analysis. 665 and 1,032 proteins were
found in close proximity of SALL1FL and
SALL1p.Arg276* (SALL1276), respectively, in
at least two independent experiments.
(D) Volcano plot representing the distribu-
tion of the candidates identiﬁed by prox-
imity proteomics in at least two out of
three independent experiments. Proteins
with at least a 2-fold change in inten-
sity with respect to the WT proteome
(log2 R 1) were considered SALL1
276-
associated candidates (orange dots). Pro-
teins with less than a 2-fold change in in-
tensity with respect to the WT proteome
(log2% 1) were considered SALL1
FL associ-
ated candidates (blue dots).
(E) Graphical representation of the log10
of the p value for each of the represented
cellular component GO terms. MT, micro-
tubule; Extracell, extracellular.
(F) Western blot of inputs or GFP-Trap
pull-downs performed in HEK293FT cells
transfected with SALL1FL-YFP (lanes 1
and 6), SALL1c.826C>T-YFP (SALl1276-YFP;
lanes 2 and 7), SALL1276-YFP together
with SALL1FL-2xHA (SALL1FL-HA; lanes 3
and 8), SALL1FL-HA together with YFP
alone (lanes 4 and 9), or YFP alone (lanes 5
and 10). Endogenous CCP110 and CEP97
were detected with speciﬁc antibodies.
GAPDH was used as a loading control.
Numbers under the CCP110 and CEP97
panels are the result of dividing the band
intensities of each lane by that of lane 1
for the inputs or by that of lane 6 for
the pull-downs. One asterisk indicates
SALL1FL-YFP, one black arrowhead indi-
cates SALL1276-YFP, and two black arrow-
heads indicate YFP alone. Molecular-
weight markers are shown to the right.Myc-BirA*-tagged SALL1c.826C>T or SALL1FL plasmids
were transfected in HEK293FT cells. Staining of transfected
cells for visualizing biotinylated proteins revealed that,
as expected, BirA*-SALL1p.Arg276* was localized diffusely
throughout the nucleus and cytoplasm, whereas BirA*-
SALL1FL was localized primarily in the nucleus and en-
riched in subnuclear domains (Figures 4A and 4B). TotalThe American Journal of Human Genlysates from Myc-BirA*-SALL1c.826C>T-
or SALL1FL-transiently transfected
cells were subjected to NeutrAvidin
pull-down, and isolated proteins
were analyzed by LC-MS/MS. In addi-tion to almost all known interactors of SALL1, such as
NuRD complex components (HDAC1, HDAC2, RbAp46,
MTA1, MTA2, MBD3, CHD4, and CHD3),38 candidates
with exclusive or enriched proximity to SALL1p.Arg276* or
SALL1FL were identiﬁed (Table S1). A total of 1,032 or 665
proteins were found in at least two out of three experi-
ments done with SALL1p.Arg276* or SALL1FL, respectivelyetics 102, 249–265, February 1, 2018 257
(Figure 4C). However, out of those proteins, 744 in the
SALL1p.Arg276* subproteomeand123 in the SALL1FL subpro-
teome were signiﬁcantly enriched at least 2-fold with
respect to the other subproteome according to label-free
protein quantitation (Figure 4D and Table S1).
With the purpose of obtaining a functional overview of
the main pathways associated with SALL1p.Arg276*, we per-
formed a comparative GO analysis to compare the
‘‘cellular component,’’ ‘‘molecular function,’’ and ‘‘biolog-
ical process’’ domains (Figure 4E, Figures S4A and S4B,
and Table S1). In the cellular component domain, a shift
toward ‘‘cytoplasm,’’ ‘‘actin,’’ and ‘‘microtubule cytoskel-
eton’’ was observed in the SALL1p.Arg276* proteome
(Figure 4E and Table S1). Intriguingly, the ‘‘centrosome’’
GO term was found exclusively in the SALL1p.Arg276* pro-
teome. Interestingly, among genes included in this cate-
gory, we found CCP110 and CEP97.39 The role described
for these proteins in cilia formation is compatible with
the phenotype observed in TBS ﬁbroblasts, so we selected
them for further study. We conﬁrmed these proteins as
proximal interactors by independent BioID experiments
analyzed by western blot by using CCP110 and CEP97
antibodies. Both proteins associated preferentially with
BirA*-SALL1p.Arg276* (Figures S4C, S4D, and S3). With
respect to molecular function, SALL1p.Arg276* showed
enrichment in cytoplasmic proteins (‘‘actin,’’ ‘‘microtu-
bule binding,’’ ‘‘ATPase activity,’’ or ‘‘helicase activity’’
terms; Figure S4A and Table S1). In the category of biolog-
ical process, the SALL1p.Arg276* subproteome showed
enrichment in the categories ‘‘cell cycle,’’ ‘‘cytoskeleton
organization,’’ and ‘‘cell response to stress’’ (Figure S4B
and Table S1).
CCP110 and CEP97 Interact with SALL1
Most cases of TBS exhibit a monoallelic truncation of
SALL1, i.e., the presence of both truncated and FL forms
of SALL1. These proteins can homo- and heterodimerize,
leading to aberrant complexes. To characterize the inter-
action between SALL1 and both CCP110 and CEP97,
we performed pull-downs with tagged SALL1FL-YFP,
SALL1p.Arg276*-YFP, or a combination of both in HEK293FT
cells. Our results showed that both endogenous CCP110
and CEP97 were able to bind to both SALL1FL and
SALL1p.Arg276* and bound preferentially to the truncated
SALL1p.Arg276*, conﬁrming our MS results (Figure 4F and
Figure S2, lanes 6 and 7). The binding to SALL1p.Arg276* per-
sisted in the presence of overexpressed SALL1FL (Figure 4F
and Figure S2, lane 8), indicating that the heterodimeriza-
tion of the truncated and FL forms does not inhibit
the interaction with CCP110 and CEP97. Note that
SALL1276-YFP can interact with SALL1FL-HA (HA panel,
lane 8), as previously suggested.35 We further demon-
strated the speciﬁcity of the interaction between SALL1
and both CCP110 and CEP97 by performing the reciprocal
experiment (Figures S4E, S4F, and S2). These results sup-
port the notion that the truncated form of SALL1, either
by itself or in complex with the FL form, can bind and258 The American Journal of Human Genetics 102, 249–265, Februarperhaps sequester or inhibit the important cilia regulatory
factors CCP110 and CEP97.
CCP110 and CEP97 Dynamics Are Altered in TBS
Fibroblasts
One key event in ciliogenesis is the depletion of CCP110
and CEP97 from the distal end of the MC, promoting the
ciliary activating program in somatic cells.39–43 On the ba-
sis of the results shown above, we hypothesized that
CCP110 and CEP97 might suffer displacements from the
MC. In order to check this hypothesis, we analyzed their
centrosomal localization in primary TBSp.Pro332Hisfs*10 ﬁ-
broblasts by immunoﬂuorescence. CCP110 was present
at the MC in a higher proportion of control cells (74%)
than TBSp.Pro332Hisfs*10 cells (36%) (Figures 5A and 5B).
Notably, 10% of the TBS cells displayed multiple foci or
more diffuse labeling of CCP110 around the centrioles,
suggesting an alteration of CCP110 dynamics (Figures
S5A and S5B). Furthermore, CEP97 was present at the
MC in 78% of the control cells but in 33% of the
TBSp.Pro332Hisfs*10 cells (Figures 5C and 5D). Therefore,
the disruption in the localization of CCP110 and CEP97
by the truncated SALL1 or by the complex between
SALL1FL and SALL1 truncations is a potential mechanism
by which CCP110 and CEP97 might be depleted from
the MC and thus lead to a higher frequency of ciliogenesis
in TBS cells.
TBS-Mimicking Cell Line Exhibits Aberrant Ciliogenesis
Our BioID experiments were done in HEK293FT cells,
which express SALL1 and are capable of forming primary
cilia. Therefore, we attempted to generate a TBS-like muta-
tion in HEK293FT cells to assess the cilia phenotype. In
addition, this would allow us to conﬁrm that the observed
differences in ciliogenesis are not dependent on the ge-
netic background of the cells, given that the TBS-like
model cell line could be compared with the parental cells.
We used the CRISPR/Cas9 method to target the SALL1
locus in the ‘‘hotspot’’ region to approximate the mutation
seen in TBSp.Pro332Hisfs*10 ﬁbroblasts. We isolated and char-
acterized a clone that is heterozygous for a SALL1mutation
with a sequence-veriﬁed single-base insertion that leads to
a frameshift and a truncated protein (SALL1c.1003dup;
SALL1p.Ser335Lysfs*20; hereinafter referred to as 293335).
In the 293335 cells, we observed dramatically less
SALL1FL than in unmodiﬁed cells (293WT) and the pres-
ence of a new 48 kDa band, corresponding to truncated
SALL1, that showed reactivity with SALL1 antibody,
(Figure 6A and Figure S2). Interestingly, localization of
SALL1FL changed in 293335 cells. Whereas SALL1FL was nu-
clear in 293WT cells, it was diffusely localized throughout
the nucleus and the cytoplasm in 293335 cells (Figure 6B).
Upon starvation and in conﬂuent conditions, cilia were
signiﬁcantly more abundant in 293335 cells (average
26%) than in 293WT cells (average 7%) (Figures 6B and
6C). Furthermore, 293335 cells displayed longer cilia
(7.0 mm on average) than did 293WT cells (5.1 mm ony 1, 2018
Figure 5. TBSp.Pro332Hisfs*10 Cells Show Changes in the Localization of CCP110 and CEP97
(A and C) Immunoﬂuorescence micrographs of cycling human-derived ﬁbroblasts stained with antibodies against endogenous CCP110
(A) or CEP97 (C) (green), CEP164 to label the mother centriole (MC; purple), and DAPI to label the nuclei (blue). Black and white images
show the single green and purple channels. Note the different distribution of CCP110 and CEP97 to the MC between TBSp.Pro332Hisfs*10
ﬁbroblasts (TBS332) and control HFFs.
(B and D) Graphical representation of the percentage of cells showing the presence of CCP110 or CEP97 at the MC per micrograph cor-
responding to the experiments in (A) or (C), respectively; n ¼ 30 micrographs. Three independent experiments were pooled together.
Pictures were taken with a Zeiss Axioimager D1 ﬂuorescence microscope with a 633 objective. All graphs represent the mean and
SEM. Scale bars, 1 mm.average) (Figures 6B and 6D). In addition, changes in cilia
length were accompanied by the absence or reduction of
CCP110 foci at the MC in most of the 293335 cells (Figures
6E–6G). Together, our results indicate that, compared with
a control of the same genetic background, truncated SALL1
is sufﬁcient to promote changes in cilia length and
CCP110 localization.
Cells Derived from Sall1-DZn2–10Mouse Embryos Exhibit
Aberrant Ciliogenesis
To further conﬁrm the results shown above, we examined
cells from a TBS animal model that had been previously
characterized. Sall1-DZn2–10 mice mimic a hotspot muta-
tion shown to cause TBS, and they produce a truncated
protein lacking most of the zinc ﬁnger motifs.11 We
analyzed cilia formation in MEFs. After conﬁrming the ge-
notype by PCR (Figure 7A), we analyzed ciliogenesis in
WT (Sall1þ/þ) and heterozygous (Sall1þ/D) MEFs. In agree-
ment with our previous results, Sall1þ/D MEFs displayed
longer (pooled average 1 mm) and more abundant (pooledThe Americaaverage 59%) cilia than Sall1þ/þ MEFs (average 0.7 mm
and 14%, respectively) both in starved conditions (Figures
7B–7D). In addition, the absence or reduction of CCP110
foci at the MC in most of the Sall1þ/D cells was also
observed in the MEFs (Figures 7E and 7F). In summary,
we have shown that MEFs derived from a mouse TBS
model reproduced the ciliary phenotype found in human
TBS ﬁbroblasts.Discussion
Phenotypes observed in TBS individuals fall within the
spectrum of those observed in ciliopathies, leading us to
speculate that cilia malfunction and/or malformation are
contributing factors in the TBS-related limb, ear, anus,
and kidney problems. Our work provides this mechanistic
connection between truncated SALL1 and primary cilia,
offering new clues about TBS etiology. In addition to its
function as a transcription factor in the nucleus, SALL1n Journal of Human Genetics 102, 249–265, February 1, 2018 259
Figure 6. Truncated SALL1 Leads to a
TBS-like Cilia Phenotype in Genetically
Modified Cells
(A) Western blot analysis of lysates from
WT HEK293FT cells (293WT) or CRISPR/
Cas9cells (293335cells). The latterweremodi-
ﬁed to mimic a TBS mutation in SALL1
(SALL1c.1003dup).A truncatedproteinofabout
48 kDa was identiﬁed in 293335 cells by
SALL1 antibody (SALL1p.Ser335Lysfs*20; arrow-
head). The asterisk indicates SALL1FL.
GAPDHwasusedas a loadingcontrol.Molec-
ular-weight markers are shown to the right.
(B) Micrographs of immunoﬂuorescence
using a speciﬁc antibody (green) show the
subcellular distribution of SALL1FL in con-
trol or mutated cells. ARL13B marks the
primary cilium (purple and yellow arrow-
heads), and DAPI marks the nuclei. Yellow
circles indicate the nuclei, and black and
white images show the single green chan-
nel. Scale bars, 5 mm.
(C and D) Graphical representation of cilia
frequency (C) and cilia length measure-
ments (D) ofmicrographs shown in (B) (cilia
frequency: n¼ 11micrographs; cilia length:
n ¼ 38 cilia in 293WT cells and n ¼ 48 cilia
in 293335 cells). Three independent experi-
ments were pooled together. The graphs
represent the mean and SEM. The p values
were calculated with a two-tailed unpaired
Student’s t test: **p < 0.01, ***p < 0.001.
(E and F) Immunoﬂuorescencemicrographs
of 293WT or 293335 cells showing centro-
somes (purple), CCP110 foci (green), and
nuclei (DAPI in blue). Scale bars, 1 mm.
Pictures were taken with a Zeiss Axioimager
D1 ﬂuorescence microscope with a 633
objective.
(G) Graphical representation of the per-
centage of cells showing CCP110 in two
foci per micrograph in 293WT or 293335
cells, corresponding to the experiments in
(E) or (F), respectively.mutations, especially those found in the hotspot that
generate mislocalized truncated proteins,3 might lead
to aberrant cilia function. Three lines of evidence support
our conclusions. First, TBS cells display signiﬁcantly
longer and more abundant cilia than control ﬁbroblasts.
Second, signaling through primary cilia is functionally
defective in TBSp.Pro332Hisfs*10 ﬁbroblasts and in Shh-
LIGHT2 cells that exogenously express the mutated form
SALL1c.826C>T. Third, proteins necessary for the formation
and function of primary cilia show altered dynamics in
TBSp.Pro332Hisfs*10 ﬁbroblasts, the 293335 TBS model cell
line, and Sall1þ/D MEFs.
Aberrant Interactions of Truncated SALL1
The presence of truncated SALL1 in the cytoplasm and
its capacity to form inappropriate protein interactions
could contribute to TBS. This hypothesis relies on the
presence of the truncated form, which we were able
to detect in TBS-derived dermal ﬁbroblasts and in a
genome-edited kidney-derived model cell line (293335).260 The American Journal of Human Genetics 102, 249–265, FebruarIn all these cases, the observed sizes of SALL1FL and its
truncated forms were higher than their expected molecu-
lar weight, as shown by western blot. This has been
previously observed12 and might be consistent with dif-
ferential SALL1 binding to SDS detergent or with the
presence of excessive proline residues that might cause
structural rigidity and thereby decrease electrophoretic
mobility. Alternatively, posttranslational modiﬁcations
could also account for variations in the expected molecu-
lar weight.
By examining dermal ﬁbroblasts, which display pri-
mary cilia and are competent for SHH signaling, we
have shown that truncated SALL1 has multiple effects
on cilia formation and function. We conclude that this
could be due to dominant-negative binding and displace-
ment of cilia-related factors by the truncated forms of
SALL1, alone or in complex with SALL1FL. Notwith-
standing, some aspects of the disease might result from
the sequestration of SALL1FL to the cytoplasm, which
might interfere with the transcriptional role of SALL1 iny 1, 2018
Figure 7. Cells Derived from Sall1þ/D Mouse Embryos Exhibit Cilia Defects
(A) PCR genotyping of MEFs derived from WT homozygous (Sall1þ/þ) or Sall1-DZn2–10 heterozygous (Sall1þ/D) embryos.
(B) Micrographs of Sall1þ/þ and Sall1þ/D MEFs analyzed during cilia assembly. Cilia were visualized by acetylated alpha-tubulin and
gamma-tubulin (AcTub and gTub, respectively; purple), and nuclei were visualized by DAPI. Scale bar, 1 mm.
(C and D) Graphical representation of cilia length (C) and cilia frequency (D) measured in Sall1þ/þ (n ¼ 38 cilia and 24 micrographs for
cilia length and frequency, respectively; blue circles) and Sall1þ/DMEFs in (B) (n¼ 37–45 cilia and n¼ 16–38micrographs for cilia length
and frequency, respectively; orange triangles).
(E) Immunoﬂuorescence micrographs of Sall1þ/þ and Sall1þ/DMEFs showing the centrosomes (AcTub, purple), CCP110 foci (green), and
nuclei (DAPI). Scale bars, 0.5 mm. Cells that underwent 48 hr of starvation were compared with non-starved cells. Pictures were taken
with a Deltavision ﬂuorescence microscope (GE Healthcare Life Sciences) with a 603 objective.
(F) Graphical representation of the percentage of cells showing CCP110 in two foci in Sall1þ/þ and Sall1þ/D MEFs in (E) (n > 10). The
graphs represent the mean and SEM. p values were calculated by one-way ANOVA: **p < 0.01, ***p < 0.001.
(G) The presence of a truncated SALL1 underlies ciliamalformations in TBS. In control cells (left), SALL1FL is mainly nuclear, and CCP110
and CEP97 localize in the mother and daughter centrioles, inhibiting cilia formation. Upon starvation, CCP110 and CEP97 are depleted
from the MC, which will allow the formation of the primary cilia. By contrast, in TBS cells (right) a truncated form of SALL1, together
with sequestered SALL1FL, localizes in the cytoplasm, where it interacts with centrosomal proteins such as CCP110 and CEP97, displac-
ing them from the MC. As a result, the frequency of cilia formation increases, and cilia are longer than in control cells. Problems in cilia
assembly are accompanied by altered SHH signaling in TBS cells.
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the nucleus, altering cilia through aberrant regulation of
downstream genes. Other SALL proteins (SALL2, SALL3,
and SALL4) might also heterodimerize with truncated
SALL111 and thus contribute to the TBS etiology, as sug-
gested by mouse studies that combine mutations in mul-
tiple Sall genes.44,45 Interestingly, it has been reported
that heterozygous deletions of SALL1 (i.e., haploinsufﬁ-
ciency) lead to a milder form of TBS,46 which might indi-
cate that a certain dosage effect contributes to the TBS
phenotype. How a reduction or loss of SALL1FL contrib-
utes to TBS etiology and cilia formation remains an
intriguing subject for future research. SALL1 is also a
transcriptional target of the SHH pathway,45,47 raising
the possibility that SALL1 is involved in feedback control,
a common theme in SHH pathway regulation (e.g.,
PTCH1 and GLI1).
Primary Cilia Aberrations in TBS-Derived Cells
Compared with controls, TBS ﬁbroblasts displayed
longer, more frequent primary cilia, and those cilia took
longer to be reabsorbed once serum was added to starved
cells. Given that the dynamic balance between antero-
grade and retrograde transport determines cilia length,48
truncated SALL1 could affect proper ciliary length by
directly or indirectly impairing ciliary transport dy-
namics.49 The presence of longer cilia in TBS-derived ﬁ-
broblasts is consistent with other studies in which ciliary
length was linked to phenotypes that overlap those
observed in TBS individuals. For instance, cells derived
from polydactylous Kif7 mutant mice displayed elon-
gated cilia.50–52 Although not observed in all individuals,
TBS can lead to polycystic kidneys. Consistently, kidney
epithelial cells derived from a mouse model of nephro-
nophthisis exhibit abnormally longer cilia. This model
develops polycystic kidney disease.53,54 Notably, a recent
study concluded that the reduction of ciliary length
attenuated cystic disease progression in these mice,55 sug-
gesting that cilia-altering therapies could be beneﬁcial to
TBS individuals.
SHH Signaling Aberrations and TBS
Because TBS-derived cells had longer and more abundant
primary cilia, we did not expect to observe defects in
SHH signaling given its dependence on intact cilia.
TBSp.Pro332Hisfs*10-derived cells were hypersensitive to stim-
ulation of the SHH pathway. Increases in SHH activity or
its expression domain in the developing limb bud can
cause preaxial polydactyly (a phenotype commonly seen
in TBS individuals) in mice, chicks, and humans.56–58
SHH signaling defects might also underlie the pathogen-
esis of anorectal malformations in TBS individuals. For
instance, it has been shown that Gli2/ mice exhibit an
imperforate anus, whereas Gli3/ mice display less severe
anal stenosis.59 In humans, some individuals with Pallis-
ter-Hall syndrome (MIM: 146510), which is caused by
mutations in GLI3 (GLI-Kruppel family member 3
[MIM: 165240]), also exhibit anorectal malformations.60262 The American Journal of Human Genetics 102, 249–265, FebruarDevelopmental pathways governing human outer-ear
morphology are largely unexplored, but SHH signaling
might be a contributing factor to TBS hearing problems
given that SHH inﬂuences both proper cochlear and sen-
sory epithelial development in mice and auditory function
in humans.61
CCP110 and CEP97, Candidate Mediators of TBS
Etiology
Our BioID experiments showed an enrichment of ciliary
and/or centrosomal proteins among the potential inter-
actors of truncated SALL1p.Arg276*, which might underlie
the observed ciliary defects. Among the SALL1p.Arg276*-
speciﬁc proximal interactors, approximately 6% of the
proteins corresponded to veriﬁed ciliary genes previously
identiﬁed by the SYSCILIA Consortium, and an addi-
tional 18% corresponded to their list of potential ciliary
genes.62 In addition, 6.5% of the SALL1p.Arg276*-speciﬁc
list was present among the 384 centrosome-localized pro-
teins identiﬁed by the Human Protein Atlas project ac-
cording to subcellular localization.63 From among these
candidates, we selected CCP110 and CEP97, which are
important negative regulators of ciliogenesis.39,49,64,65
The removal of these regulators is a key early event in
ciliogenesis: depletion of CCP110 and CEP97 leads to
the premature formation of aberrant cilia, whereas their
overexpression blocks ciliogenesis, consistent with the
increased frequency of primary cilia in TBS-derived cells.
Although some studies demonstrated that removal of
CCP110 was sufﬁcient to induce ectopic cilia forma-
tion,39,41 others reported that its depletion promoted
abnormal elongation of non-docked centriolar micro-
tubules.64,66 A recent publication suggested that a
context-dependent role of CCP110 in cilia formation
is linked to its interactors in a particular subcellular
environment.67 Importantly, consistent with altered
CCP110 localization at the MC in TBSp.Pro332Hisfs*10 cells,
CCP110-KO mice exhibited preaxial polydactyly, heart
malformations, and cleft palate among other problems.
Understanding the exact contribution of CCP110 and
its protein interaction network in the context of TBS,
which could function in a tissue- or organ-dependent
manner, would be of high relevance.
In conclusion, we propose that TBS is a potential
ciliopathy-like disease with symptoms caused by trun-
cated SALL1’s interference with the normal function of
cilia and/or centrosomal-related proteins (Figure 7G).
The ciliopathies are an expanding class of human genetic
disorders, and our work provides a framework for
understanding TBS with a focus on primary cilia. This
does not rule out a disruption in the nuclear role of
SALL1 or dominant interactions with other proteins
in the SALL family. Different alleles might exhibit
different strengths depending on the interactors. Ge-
netic, environmental, or stochastic modiﬁers also might
inﬂuence the phenotypic spectrum in TBS individuals
(see GeneReviews in the Web Resources).11 Deﬁningy 1, 2018
the degree to which primary cilia and other factors are
implicated in the etiology of TBS could drive future ther-
apeutic approaches.Supplemental Data
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